Functional Genomics for Cancer Drug Target Discovery

被引：52

作者：

Haley, Benjamin ^{[1
]}

Roudnicky, Filip ^{[2
]}

机构：

[1] Genentech Inc, Mol Biol Dept, 1 DNA Way, San Francisco, CA 94080 USA

[2] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, CH-4070 Basel, Switzerland

来源：

CANCER CELL | 2020年 / 38卷 / 01期

关键词：

LARGE-SCALE; SYNTHETIC LETHALITY; CRISPR-CAS9; SCREENS; GENE ESSENTIALITY; RNAI; SHRNA; GUIDE; IDENTIFICATION; CRISPR/CAS9; MUTAGENESIS;

D O I：

10.1016/j.ccell.2020.04.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Functional genomics describes a field of biology that uses a range of approaches for assessing gene function with high-throughput molecular, genetic, and cellular technologies. The near limitless potential for applying these concepts to study the activities of all genetic loci has completely upended how today's cancer biologists tackle drug target discovery. We provide an overview of contemporary functional genomics platforms, highlighting areas of distinction and complementarity across technologies, so as to aid in the development or interpretation of cancer-focused screening efforts.

引用

页码：31 / 43

页数：13

共 153 条

[1] C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector [J].

Abudayyeh, Omar O. ;

Gootenberg, Jonathan S. ;

Konermann, Silvana ;

Joung, Julia ;

Slaymaker, Ian M. ;

Cox, David B. T. ;

Shmakov, Sergey ;

Makarova, Kira S. ;

Semenova, Ekaterina ;

Minakhin, Leonid ;

Severinov, Konstantin ;

Regev, Aviv ;

Lander, Eric S. ;

Koonin, Eugene V. ;

Zhang, Feng .

SCIENCE, 2016, 353 (6299)

[2] Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting [J].

Aguirre, Andrew J. ;

Meyers, Robin M. ;

Weir, Barbara A. ;

Vazquez, Francisca ;

Zhang, Cheng-Zhong ;

Ben-David, Uri ;

Cook, April ;

Ha, Gavin ;

Harrington, William F. ;

Doshi, Mihir B. ;

Kost-Alimova, Maria ;

Gill, Stanley ;

Xu, Han ;

Ali, Levi D. ;

Jiang, Guozhi ;

Pantel, Sasha ;

Lee, Yenarae ;

Goodale, Amy ;

Cherniack, Andrew D. ;

Oh, Coyin ;

Kryukov, Gregory ;

Cowley, Glenn S. ;

Garraway, Levi A. ;

Stegmaier, Kimberly ;

Roberts, Charles W. ;

Golub, Todd R. ;

Meyerson, Matthew ;

Root, David E. ;

Tsherniak, Aviad ;

Hahn, William C. .

CANCER DISCOVERY, 2016, 6 (08) :914-929

[3] Predicting the mutations generated by repair of Cas9-induced double-strand breaks [J].

Allen, Felicity ;

Crepaldi, Luca ;

Alsinet, Clara ;

Strong, Alexander J. ;

Kleshchevnikov, Vitalii ;

De Angeli, Pietro ;

Palenikova, Petra ;

Khodak, Anton ;

Kiselev, Vladimir ;

Kosicki, Michael ;

Bassett, Andrew R. ;

Harding, Heather ;

Galanty, Yaron ;

Munoz-Martinez, Francisco ;

Metzakopian, Emmanouil ;

Jackson, Stephen P. ;

Parts, Leopold .

NATURE BIOTECHNOLOGY, 2019, 37 (01) :64-+

[4] Search-and-replace genome editing without double-strand breaks or donor DNA [J].

Anzalone, Andrew V. ;

Randolph, Peyton B. ;

Davis, Jessie R. ;

Sousa, Alexander A. ;

Koblan, Luke W. ;

Levy, Jonathan M. ;

Chen, Peter J. ;

Wilson, Christopher ;

Newby, Gregory A. ;

Raguram, Aditya ;

Liu, David R. .

NATURE, 2019, 576 (7785) :149-+

[5] STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells [J].

Babij, Carol ;

Zhang, Yihong ;

Kurzeja, Robert J. ;

Munzli, Anke ;

Shehabeldin, Amro ;

Fernando, Manory ;

Quon, Kim ;

Kassner, Paul D. ;

Ruefli-Brasse, Astrid A. ;

Watson, Vivienne J. ;

Fajardo, Flordeliza ;

Jackson, Angela ;

Zondlo, James ;

Sun, Yu ;

Ellison, Aaron R. ;

Plewa, Cherylene A. ;

San Miguel, Tisha ;

Robinson, John ;

McCarter, John ;

Schwandner, Ralf ;

Judd, Ted ;

Carnahan, Josette ;

Dussault, Isabelle .

CANCER RESEARCH, 2011, 71 (17) :5818-5826

[6]

Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]

[7] Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens [J].

Behan, Fiona M. ;

Iorio, Francesco ;

Picco, Gabriele ;

Goncalves, Emanuel ;

Beaver, Charlotte M. ;

Migliardi, Giorgia ;

Santos, Rita ;

Rao, Yanhua ;

Sassi, Francesco ;

Pinnelli, Marika ;

Ansari, Rizwan ;

Harper, Sarah ;

Jackson, David Adam ;

Mcrae, Rebecca ;

Pooley, Rachel ;

Wilkinson, Piers ;

van der Meer, Dieudonne ;

Dow, David ;

Buser-Doepner, Carolyn ;

Bertotti, Andrea ;

Trusolino, Livio ;

Stronach, Euan A. ;

Saez-Rodriguez, Julio ;

Yusa, Kosuke ;

Garnett, Mathew J. .

NATURE, 2019, 568 (7753) :511-+

[8] A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].

Berns, K ;

Hijmans, EM ;

Mullenders, J ;

Brummelkamp, TR ;

Velds, A ;

Heimerikx, M ;

Kerkhoven, RM ;

Madiredjo, M ;

Nijkamp, W ;

Weigelt, B ;

Agami, R ;

Ge, W ;

Cavet, G ;

Linsley, PS ;

Beijersbergen, RL ;

Bernards, R .

NATURE, 2004, 428 (6981) :431-437

[9] An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance [J].

Bester, Assaf C. ;

Lee, Jonathan D. ;

Chavez, Alejandro ;

Lee, Yu-Ru ;

Nachmani, Daphna ;

Vora, Suhani ;

Victor, Joshua ;

Sauvageau, Martin ;

Monteleone, Emanuele ;

Rinn, John L. ;

Provero, Paolo ;

Church, George M. ;

Clohessy, John G. ;

Pandolfi, Pier Paolo .

CELL, 2018, 173 (03) :649-+

[10] Gene essentiality and synthetic lethality in haploid human cells [J].

Blomen, Vincent A. ;

Majek, Peter ;

Jae, Lucas T. ;

Bigenzahn, Johannes W. ;

Nieuwenhuis, Joppe ;

Staring, Jacqueline ;

Sacco, Roberto ;

van Diemen, Ferdy R. ;

Olk, Nadine ;

Stukalov, Alexey ;

Marceau, Caleb ;

Janssen, Hans ;

Carette, Jan E. ;

Bennett, Keiryn L. ;

Colinge, Jacques ;

Superti-Furga, Giulio ;

Brummelkamp, Thijn R. .

SCIENCE, 2015, 350 (6264) :1092-1096

← 1 2 3 4 5 6 7 8 9 10 →